Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Longboard Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +25 vs. Q1 2023
- Shares held
- 14.5M
- +1.35M (+10.2%) vs. Q1 2023
- Total value
- $106.7M
- +$55.3M (+107.4%) vs. Q1 2023
- New holders
- 27
- 14 more added
- Sold out
- 2
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 125 | $1.33B |
| Q2 2024 | 100 | $1.05B |
| Q1 2024 | 105 | $819.5M |
| Q4 2023 | 52 | $99.7M |
| Q3 2023 | 51 | $87.1M |
| Q2 2023 | 50 | $106.7M |
| Q1 2023 | 25 | $51.5M |
| Q4 2022 | 18 | $23.3M |
| Q3 2022 | 19 | $27.0M |
| Q2 2022 | 20 | $23.3M |
| Q1 2022 | 21 | $40.1M |
| Q4 2021 | 21 | $37.8M |
| Q3 2021 | 20 | $68.2M |
| Q2 2021 | 17 | $71.7M |
| Q1 2021 | 22 | $142.8M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Longboard Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 521 | $3.82K | 0.00% | −2,516−82.8% | Reduced |
| Metropolitan Life Insurance Co | 926 | $6.80K | 0.00% | +926 | New |
| Ameritas Investment Partners, Inc. | 1,286 | $9.44K | 0.00% | +1,286 | New |
| Legal & General Group Plc | 1,670 | $12.3K | 0.00% | +1,670 | New |
| Amalgamated Bank | 1,808 | $13.0K | 0.00% | +1,808 | New |
| Royal Bank of Canada | 1,751 | $13.0K | 0.00% | +1,751 | New |
| Barclays PLC | 3,124 | $22.9K | 0.00% | +3,124 | New |
| STRS Ohio | 3,200 | $23.0K | 0.00% | +3,200 | New |
| Dorsey Wright & Associates | 3,150 | $23.1K | 0.01% | +3,150 | New |
| Citigroup Inc | 4,638 | $34.0K | 0.00% | +1,870+67.6% | Added |
| California State Teachers Retirement System | 5,182 | $38.0K | 0.00% | +5,182 | New |
| Wells Fargo & Company | 6,147 | $45.1K | 0.00% | +6,053+6,439.4% | Added |
| American International Group, Inc. | 7,498 | $55.0K | 0.00% | +7,498 | New |
| MetLife Investment Management | 8,932 | $65.6K | 0.00% | +8,932 | New |
| UBS Group AG | 9,059 | $66.5K | 0.00% | +8,531+1,615.7% | Added |
| Morgan Stanley | 10,820 | $79.4K | 0.00% | +10,651+6,302.4% | Added |
| Goldman Sachs Group Inc | 10,914 | $80.1K | 0.00% | +10,914 | New |
| New York State Common Retirement Fund | 11,900 | $87.3K | 0.00% | +11,900 | New |
| Bank of America Corp | 11,984 | $88.0K | 0.00% | +11,984 | New |
| Rhumbline Advisers | 15,382 | $112.9K | 0.00% | +15,382 | New |
| Renaissance Technologies LLC | 15,700 | $115.0K | 0.00% | +15,700 | New |
| Bank of Montreal | 15,488 | $126.4K | 0.00% | +15,488 | New |
| Nuveen Asset Management, LLC | 21,812 | $160.1K | 0.00% | +21,812 | New |
| Laurion Capital Management LP | 30,918 | $226.9K | 0.01% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 38,803 | $284.8K | 0.00% | +10,554+37.4% | Added |
| Charles Schwab Investment Management Inc | 42,933 | $315.1K | 0.00% | +42,933 | New |
| Moore Capital Management, LP | 45,728 | $335.6K | 0.01% | +45,728 | New |
| Bank of New York Mellon Corp | 45,752 | $335.8K | 0.00% | +45,752 | New |
| TD Asset Management Inc | 48,611 | $356.8K | 0.00% | +11,000+29.2% | Added |
| Bridgeway Capital Management, LLC | 50,000 | $367.0K | 0.01% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 87,000 | $638.6K | 0.01% | +87,000 | New |
| Boothbay Fund Management, LLC | 102,766 | $754.3K | 0.03% | +102,766 | New |
| Woodline Partners LP | 113,334 | $831.9K | 0.01% | −1,235−1.1% | Reduced |
| Northern Trust Corp | 134,147 | $984.6K | 0.00% | +116,357+654.1% | Added |
| CIBC Asset Management Inc | 144,571 | $1.06M | 0.00% | +88,446+157.6% | Added |
| UBS Oconnor LLC | 262,265 | $1.93M | 0.04% | +32,265+14.0% | Added |
| State Street Corp | 294,485 | $2.16M | 0.00% | +294,485 | New |
| Geode Capital Management, LLC | 329,707 | $2.42M | 0.00% | +247,801+302.5% | Added |
| Parkman Healthcare Partners LLC | 341,587 | $2.51M | 0.43% | +341,587 | New |
| Ikarian Capital, LLC | 504,253 | $3.70M | 1.31% | +504,253 | New |
| JPMorgan Chase & Co | 567,305 | $4.16M | 0.00% | +567,305 | New |
| Integral Health Asset Management, LLC | 598,000 | $4.39M | 0.58% | +16,000+2.7% | Added |
| Vanguard Group Inc | 667,199 | $4.90M | 0.00% | +268,720+67.4% | Added |
| Prosight Management, LP | 734,897 | $5.39M | 1.58% | −165,703−18.4% | Reduced |
| BlackRock Inc. | 740,603 | $5.44M | 0.00% | +711,581+2,451.9% | Added |
| Point72 Asset Management, L.P. | 825,000 | $6.06M | 0.02% | −425,000−34.0% | Reduced |
| Farallon Capital Management, L.L.C. | 1,000,000 | $7.34M | 0.04% | −560,500−35.9% | Reduced |
| Price T Rowe Associates Inc | 1,691,330 | $12.4M | 0.00% | +226,556+15.5% | Added |
| Cormorant Asset Management, LP | 2,353,141 | $17.3M | 0.98% | 00.0% | Unchanged |
| FMR LLC | 2,569,157 | $18.9M | 0.00% | −331,235−11.4% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,047,705−100.0% | Sold out |
| Bourgeon Capital Management LLC | 0 | $0 | 0.00% | −49,855−100.0% | Sold out |